Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
Streamlining Phase 1 Trials With The Mobile Vision Pod
A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.
The Implications Of Semaglutide's Connect To Increased Risk Of NAION
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
Planning For High-Performance Hematologic Oncology Clinical Trials
Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.

Strengthening Psychiatric Eligibility In CNS Trials
2/21/2025

Learn how Independent Psychiatric Eligibility Reviews provide a standardized, objective approach to screening, improving diagnostic accuracy, reducing bias, and enhancing trial integrity.
Uncovering The Root Cause Of Clinical Trial Troubles
12/10/2024

Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
Endometrial Cancer — Global Clinical Trial Landscape (2024)
5/17/2024

Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.
Navigating Wearable Integration: Key Operational Considerations
4/5/2024

Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.
Examining A Phase 1 COVID-19 Clinical Trial
5/10/2024

Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.

IRB Review Services For Phase I Research

With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.
Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility

Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
Intelligent Trials - Diversity

Medidata AI’s Intelligent Trials solution provides insights that allow you to take action to improve study diversity during the planning stages.
TrialScope Disclose

With TrialScope Disclose, study sponsors streamline and optimize the entire clinical trial disclosure process from initial registration to final results — mitigating risk, maximizing transparency and ultimately moving healthcare forward.
Accelerate Approval Of Novel Therapies

Learn how to make critical, data-driven decisions throughout the product development lifecycle and increase new therapies' probability of success.